Patients with schizophrenia and type 2 diabetes prescribed GLP-1 receptor agonists were 29% less likely to visit an emergency department for a mental health crisis compared to those not taking GLP-1s, according to a Lancet Psychiatry study

From the articleGLP-1 Drugs Cut Schizophrenia Hospital Visits, Study FindsAlso in GLP-1s and schizophrenia: Drug is linked to lower need for acute care in patients with schizophrenia and type 2 diabetes, study suggests